Fin Trust Capital Advisors, LLC Repligen Corp Transaction History
Fin Trust Capital Advisors, LLC
- $510 Million
- Q1 2024
A detailed history of Fin Trust Capital Advisors, LLC transactions in Repligen Corp stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 35 shares of RGEN stock, worth $4,204. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35
Previous 35
-0.0%
Holding current value
$4,204
Previous $6,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RGEN
# of Institutions
522Shares Held
53.2MCall Options Held
1.05MPut Options Held
228K-
Black Rock Inc. New York, NY7.77MShares$934 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$613 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$429 Million0.08% of portfolio
-
State Street Corp Boston, MA1.76MShares$211 Million0.01% of portfolio
-
Macquarie Group LTD Australia, C31.46MShares$176 Million0.31% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $6.67B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....